<p>Pennant Group Inc ((PNTG)) 已召开其第一季度财报电话会议。以下是会议的主要亮点。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者推荐</li>
</ul>
<p>Pennant Group 最近的财报电话会议传达了谨慎乐观的基调，管理层强调了通过收购和家庭健康与临终关怀的有机增长推动的强劲收入和利润增长，同时老年生活的利润率也在改善。然而，管理层也强调了整合成本、电子病历过渡的干扰以及适度的流动性作为短期限制，敦促投资者预期在大型收购被吸收时会出现一些波动。</p>
<h2>强劲的收入增长和利润改善</h2>
<p>Pennant 报告的 GAAP 收入为 2.854 亿美元，同比增长 36%，主要得益于收购扩张和稳健的有机表现。GAAP 净收入增长 9.6% 至 850 万美元，而调整后的净收入增长 19.8% 至 1150 万美元，使调整后的稀释每股收益达到 0.32 美元，比去年同期增长 18.5%。</p>
<h2>尽管整合拖累，调整后的 EBITDA 仍在攀升</h2>
<p>调整后的 EBITDA 达到 2170 万美元，增长 32.6%，反映出整个投资组合的运营杠杆改善。在不考虑非控股权益的情况下，调整后的 EBITDA 增长 37.2% 至 2350 万美元，显示出尽管整合和过渡成本对表面利润率造成压力，但基础盈利能力仍在扩展。</p>
<h2>家庭健康与临终关怀推动细分市场表现优异</h2>
<p>家庭健康与临终关怀细分市场仍然是增长的引擎，产生收入 2.291 亿美元，同比增长 43.3%。该细分市场的调整后 EBITDA 增长 33.7% 至 3360 万美元，而在不考虑非控股权益的情况下，调整后的 EBITDA 增长 36.6% 至 3540 万美元，突显了护理连续体战略的强大。</p>
<h2>家庭健康量激增，门店表现稳健</h2>
<p>家庭健康的总入院人数激增 62.7% 至 30721 人，医疗保险入院人数增长 75.1% 至 13303 人，反映出收购和强劲的需求。门店表现也健康，总入院人数增长 5.8%，同店医疗保险入院人数增长 9.2%，显示出超出收购范围的有机增长。</p>
<h2>临终关怀的增长得益于良好的临床结果</h2>
<p>临终关怀的平均每日住院人数同比增长 37% 至 5199 人，同店住院人数增长 10.2% 至 3952 人，突显出广泛的扩张。管理层指出了有利的临床结果，包括关键机构的高访问率，并提到与拟议的 2026 年临终关怀费率增加的对齐，为业务的进一步增长奠定了基础。</p>
<h2>门店利润率在整个投资组合中增强</h2>
<p>在不考虑非控股权益的情况下，同店细分市场的调整后 EBITDA 利润率提高至 17.2%，同比增长 110 个基点。这一利润率的扩张表明了显著的运营杠杆和生产力提升，尽管持续的过渡活动和整合相关的噪音仍在进行。</p>
<h2>老年生活通过收购和利润率提升实现反弹</h2>
<p>老年生活的收入达到 5630 万美元，同比增长 12.6%，得益于包括 Lavender Lane 在内的收购，以及在季度结束后关闭的三个社区。调整后的 EBITDA 增长 30.6% 至 640 万美元，细分市场的利润率提高 190 个基点至 11.8%，得益于同店入住率上升至 81%，增加了 180 个基点。</p>
<h2>领导层储备加深以支持扩展</h2>
<p>Pennant 强调了对领导力发展的投资，提到计划在 2025 年和 2026 年进行重要的增补和晋升。公司目前拥有 55 位首席执行官和 92 位其他 C 级领导，建立了一个广泛的管理储备，以支持增长并在新市场中执行复杂的整合。</p>
<h2>资产负债表和现金流趋势向好</h2>
<p>净债务与调整后 EBITDA 的比率为 1.93 倍，反映出适度的杠杆，因为公司继续投资于增长。运营中使用的现金显著改善至 340 万美元，同比改善 1780 万美元，尽管在信贷设施下的总借款达到 1.708 亿美元。</p>
<h2>整合成本对报告利润率造成压力</h2>
<p>尽管盈利增长强劲，家庭健康与临终关怀的调整后 EBITDA 利润率在不考虑非控股权益的情况下下降 70 个基点至 15.5%，这是预期之中的。管理层将压力归因于超过 50 个新运营的过渡和过渡服务协议下的临时高成本，将这些视为对结构性更强平台的短期阻力。</p>
<h2>EMR 过渡和天气影响短期运营</h2>
<p>高管们指出，由于电子病历过渡和季节性因素（包括严重的 1 月天气），运营受到干扰，这暂时对住院人数和入院人数造成压力。在电话会议时，东南部的五个整合波次中只有两个完全迁移，最大的波次尚未到来，增加了短期执行风险。</p>
<h2>收购驱动的老年生活入住率波动</h2>
<p>尽管同店入住率有所改善，但所有店铺的老年生活入住率环比下降约 200 个基点，主要由于新收购的低入住率社区和假日季节性。管理层将此视为与收购相关的波动，预计随着整合的推进，入住率和盈利能力将逐渐正常化。</p>
<h2>流动性紧张但在当前杠杆下可控</h2>
<p>Pennant 在季度末手头有 490 万美元现金，而未偿还借款为 1.708 亿美元，留下相对薄弱的现金缓冲。管理层认为，杠杆在调整后 EBITDA 的两倍以下仍然合理，但承认持续的资本支出和整合支出在短期内收紧了灵活性。</p>
<h2>劳动力和报销压力仍然是关键风险</h2>
<p>公司继续面临工资通胀，特别是在临床岗位上，即使在推动生产力提升和人员优化的同时。与此同时，医疗保险家庭健康基础费率降低 1.3% 限制了收入增长，迫使 Pennant 通过提高效率和严格控制成本来抵消报销压力。</p>
<h2>高额资本支出和一次性整合支出</h2>
<p>年初资本支出较高，因为 Pennant 在东南部投资于老年生活整合和基础设施建设。管理层重申全年资本支出预期约为 1500 万至 1800 万美元，并指出支出是前期集中，可能在短期内造成拖累，直到收益显现。</p>
<h2>监管审查和临终关怀 CAP 风险</h2>
<p>公司正在密切关注临终关怀 CAP 限制，某些州面临特别压力，同时承认对欺诈、浪费和滥用的监管关注加大。管理层看到广泛执法行动带来的潜在风险，但也认为随着不合规运营商的退出，竞争环境的改善是一个机会。</p>
<h2>在整合不确定性下的保守指引</h2>
<p>Pennant 维持了全年指引，但表示业绩正朝着范围的上限发展，第一季度支持了双位数的收入和 EBITDA 增长。领导层表示将在第二季度后重新评估，提到东南部整合波的持续以及逐步退出过渡服务协议的过渡，以及 2026 年临终关怀费率提高的潜在利好。</p>
<p>Pennant 的财报电话会议描绘了一家正在进行激进但大体上执行良好的扩张公司的图景，强劲的收入增长、上升的 EBITDA 以及关键细分市场的同店指标改善。投资者现在将关注管理层是否能够在不牺牲本季度业绩支撑的利润率增长和交易量动能的情况下，顺利应对 EMR 过渡、整合风险和更紧的流动性。</p>

PNTG

<p>Pennant Group Inc (PNTG) 报告了强劲的第一季度业绩，收入同比增长 36%，达到 2.854 亿美元，主要得益于收购和家庭健康与临终关怀业务的有机增长。调整后的净收入增长 19.8%，达到 1150 万美元。然而，整合成本和电子病历过渡的干扰在短期内构成挑战。家庭健康与临终关怀部门的收入激增 43.3%，而老年生活收入增长 12.6%。尽管运营受到干扰，管理层对未来增长仍持乐观态度，强调领导力发展和改善利润率的重点</p>

<p>Pennant Group Inc ((PNTG)) has held its Q1 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>Pennant Group Inc ((PNTG)) 已召开其第一季度财报电话会议。以下是会议的主要亮点。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者推荐</li>
</ul>
</div><p>Pennant Group’s latest earnings call struck a cautiously upbeat tone, as management highlighted strong revenue and profit growth powered by acquisitions and organic gains in Home Health &amp; Hospice, alongside improving margins in Senior Living. However, executives also underscored integration costs, EMR transition disruptions, and modest liquidity as near‑term constraints, urging investors to expect some choppiness as large acquisitions are absorbed.</p>
<div class="lb-trans"><p>Pennant Group 最近的财报电话会议传达了谨慎乐观的基调，管理层强调了通过收购和家庭健康与临终关怀的有机增长推动的强劲收入和利润增长，同时老年生活的利润率也在改善。然而，管理层也强调了整合成本、电子病历过渡的干扰以及适度的流动性作为短期限制，敦促投资者预期在大型收购被吸收时会出现一些波动。</p>
</div><h2>Strong top-line growth and profit improvement</h2>
<div class="lb-trans"><h2>强劲的收入增长和利润改善</h2>
</div><p>Pennant reported GAAP revenue of $285.4 million, up 36% year over year, driven by acquisitive expansion and solid organic performance. GAAP net income rose 9.6% to $8.5 million, while adjusted net income climbed 19.8% to $11.5 million, pushing adjusted diluted EPS to $0.32, an 18.5% increase from the prior-year quarter.</p>
<div class="lb-trans"><p>Pennant 报告的 GAAP 收入为 2.854 亿美元，同比增长 36%，主要得益于收购扩张和稳健的有机表现。GAAP 净收入增长 9.6% 至 850 万美元，而调整后的净收入增长 19.8% 至 1150 万美元，使调整后的稀释每股收益达到 0.32 美元，比去年同期增长 18.5%。</p>
</div><h2>Adjusted EBITDA climbs despite integration drag</h2>
<div class="lb-trans"><h2>尽管整合拖累，调整后的 EBITDA 仍在攀升</h2>
</div><p>Adjusted EBITDA reached $21.7 million, a 32.6% jump, reflecting improved operating leverage across the portfolio. On a prior-to-noncontrolling-interest basis, adjusted EBITDA rose 37.2% to $23.5 million, showing the underlying profitability expansion even as integration and transition costs weighed on headline margins.</p>
<div class="lb-trans"><p>调整后的 EBITDA 达到 2170 万美元，增长 32.6%，反映出整个投资组合的运营杠杆改善。在不考虑非控股权益的情况下，调整后的 EBITDA 增长 37.2% 至 2350 万美元，显示出尽管整合和过渡成本对表面利润率造成压力，但基础盈利能力仍在扩展。</p>
</div><h2>Home Health &amp; Hospice drives segment outperformance</h2>
<div class="lb-trans"><h2>家庭健康与临终关怀推动细分市场表现优异</h2>
</div><p>The Home Health &amp; Hospice segment remained the engine of growth, generating revenue of $229.1 million, up 43.3% year over year. Segment adjusted EBITDA rose 33.7% to $33.6 million, and adjusted EBITDA prior to noncontrolling interest increased 36.6% to $35.4 million, underscoring the strength of the care continuum strategy.</p>
<div class="lb-trans"><p>家庭健康与临终关怀细分市场仍然是增长的引擎，产生收入 2.291 亿美元，同比增长 43.3%。该细分市场的调整后 EBITDA 增长 33.7% 至 3360 万美元，而在不考虑非控股权益的情况下，调整后的 EBITDA 增长 36.6% 至 3540 万美元，突显了护理连续体战略的强大。</p>
</div><h2>Home Health volumes surge with solid same-store gains</h2>
<div class="lb-trans"><h2>家庭健康量激增，门店表现稳健</h2>
</div><p>Total Home Health admissions surged 62.7% to 30,721, with Medicare admissions up 75.1% to 13,303, reflecting both acquisitions and robust demand. Same-store performance was also healthy, as total admissions grew 5.8% and same-store Medicare admissions rose 9.2%, signaling organic growth beyond the acquired footprint.</p>
<div class="lb-trans"><p>家庭健康的总入院人数激增 62.7% 至 30721 人，医疗保险入院人数增长 75.1% 至 13303 人，反映出收购和强劲的需求。门店表现也健康，总入院人数增长 5.8%，同店医疗保险入院人数增长 9.2%，显示出超出收购范围的有机增长。</p>
</div><h2>Hospice growth supported by strong clinical outcomes</h2>
<div class="lb-trans"><h2>临终关怀的增长得益于良好的临床结果</h2>
</div><p>Hospice average daily census rose 37% year over year to 5,199, with same-store census climbing 10.2% to 3,952, highlighting broad-based expansion. Management pointed to favorable clinical outcomes, including high visit rates at key agencies, and noted alignment with the proposed 2026 hospice rate increase, positioning the business for further upside.</p>
<div class="lb-trans"><p>临终关怀的平均每日住院人数同比增长 37% 至 5199 人，同店住院人数增长 10.2% 至 3952 人，突显出广泛的扩张。管理层指出了有利的临床结果，包括关键机构的高访问率，并提到与拟议的 2026 年临终关怀费率增加的对齐，为业务的进一步增长奠定了基础。</p>
</div><h2>Same-store margins strengthen across the portfolio</h2>
<div class="lb-trans"><h2>门店利润率在整个投资组合中增强</h2>
</div><p>Same-store segment adjusted EBITDA margin prior to noncontrolling interest improved to 17.2%, an increase of 110 basis points year over year. This margin expansion indicates meaningful operational leverage and productivity gains, achieved despite ongoing transition activity and integration-related noise.</p>
<div class="lb-trans"><p>在不考虑非控股权益的情况下，同店细分市场的调整后 EBITDA 利润率提高至 17.2%，同比增长 110 个基点。这一利润率的扩张表明了显著的运营杠杆和生产力提升，尽管持续的过渡活动和整合相关的噪音仍在进行。</p>
</div><h2>Senior Living rebounds with acquisitions and margin gains</h2>
<div class="lb-trans"><h2>老年生活通过收购和利润率提升实现反弹</h2>
</div><p>Senior Living revenue reached $56.3 million, up 12.6%, supported by acquisitions including Lavender Lane and three communities closed after quarter end. Adjusted EBITDA rose 30.6% to $6.4 million, and segment margins improved 190 basis points to 11.8%, aided by rising same-store occupancy of 81%, up 180 basis points.</p>
<div class="lb-trans"><p>老年生活的收入达到 5630 万美元，同比增长 12.6%，得益于包括 Lavender Lane 在内的收购，以及在季度结束后关闭的三个社区。调整后的 EBITDA 增长 30.6% 至 640 万美元，细分市场的利润率提高 190 个基点至 11.8%，得益于同店入住率上升至 81%，增加了 180 个基点。</p>
</div><h2>Leadership bench deepens to support scaling</h2>
<div class="lb-trans"><h2>领导层储备加深以支持扩展</h2>
</div><p>Pennant emphasized investments in leadership development, citing significant additions and promotions planned through 2025 and 2026. The company now counts 55 CEOs and 92 other C‑level leaders in operations, establishing a broad management bench designed to sustain growth and execute complex integrations across new markets.</p>
<div class="lb-trans"><p>Pennant 强调了对领导力发展的投资，提到计划在 2025 年和 2026 年进行重要的增补和晋升。公司目前拥有 55 位首席执行官和 92 位其他 C 级领导，建立了一个广泛的管理储备，以支持增长并在新市场中执行复杂的整合。</p>
</div><h2>Balance sheet and cash flow trend in the right direction</h2>
<div class="lb-trans"><h2>资产负债表和现金流趋势向好</h2>
</div><p>Net debt to adjusted EBITDA stood at 1.93 times, reflecting moderate leverage as the company continues to invest in growth. Cash used in operations improved significantly to $3.4 million, a $17.8 million year-over-year improvement, even as total borrowings under the credit facility reached $170.8 million.</p>
<div class="lb-trans"><p>净债务与调整后 EBITDA 的比率为 1.93 倍，反映出适度的杠杆，因为公司继续投资于增长。运营中使用的现金显著改善至 340 万美元，同比改善 1780 万美元，尽管在信贷设施下的总借款达到 1.708 亿美元。</p>
</div><h2>Integration costs weigh on reported margins</h2>
<div class="lb-trans"><h2>整合成本对报告利润率造成压力</h2>
</div><p>Despite robust earnings growth, Home Health &amp; Hospice adjusted EBITDA margin prior to noncontrolling interest slipped 70 basis points to 15.5%, as expected. Management attributed the pressure to the transition of more than 50 new operations and temporary higher costs under a transition services agreement, framing these as short-term headwinds to a structurally stronger platform.</p>
<div class="lb-trans"><p>尽管盈利增长强劲，家庭健康与临终关怀的调整后 EBITDA 利润率在不考虑非控股权益的情况下下降 70 个基点至 15.5%，这是预期之中的。管理层将压力归因于超过 50 个新运营的过渡和过渡服务协议下的临时高成本，将这些视为对结构性更强平台的短期阻力。</p>
</div><h2>EMR transitions and weather disrupt near-term operations</h2>
<div class="lb-trans"><h2>EMR 过渡和天气影响短期运营</h2>
</div><p>Executives flagged operational disruption from electronic medical record transitions and seasonal factors, including severe January weather, which temporarily pressured census and admissions. At the time of the call, only two of five integration waves in the Southeast were fully migrated, with the largest waves ahead, heightening near-term execution risk.</p>
<div class="lb-trans"><p>高管们指出，由于电子病历过渡和季节性因素（包括严重的 1 月天气），运营受到干扰，这暂时对住院人数和入院人数造成压力。在电话会议时，东南部的五个整合波次中只有两个完全迁移，最大的波次尚未到来，增加了短期执行风险。</p>
</div><h2>Acquisition-driven occupancy volatility in Senior Living</h2>
<div class="lb-trans"><h2>收购驱动的老年生活入住率波动</h2>
</div><p>While same-store occupancy improved, all-store Senior Living occupancy declined about 200 basis points sequentially, largely due to newly acquired, low-occupancy communities and holiday seasonality. Management framed this as acquisition-related lumpiness, with expectations that occupancy and profitability will gradually normalize as integration progresses.</p>
<div class="lb-trans"><p>尽管同店入住率有所改善，但所有店铺的老年生活入住率环比下降约 200 个基点，主要由于新收购的低入住率社区和假日季节性。管理层将此视为与收购相关的波动，预计随着整合的推进，入住率和盈利能力将逐渐正常化。</p>
</div><h2>Liquidity tight but manageable under current leverage</h2>
<div class="lb-trans"><h2>流动性紧张但在当前杠杆下可控</h2>
</div><p>Pennant ended the quarter with $4.9 million of cash on hand against $170.8 million of outstanding borrowings, leaving a relatively thin cash cushion. Management argued that leverage remains reasonable at under two times adjusted EBITDA, but acknowledged that ongoing capex and integration spending tighten flexibility in the near term.</p>
<div class="lb-trans"><p>Pennant 在季度末手头有 490 万美元现金，而未偿还借款为 1.708 亿美元，留下相对薄弱的现金缓冲。管理层认为，杠杆在调整后 EBITDA 的两倍以下仍然合理，但承认持续的资本支出和整合支出在短期内收紧了灵活性。</p>
</div><h2>Labor and reimbursement pressure remain key risks</h2>
<div class="lb-trans"><h2>劳动力和报销压力仍然是关键风险</h2>
</div><p>The company continues to face wage inflation, particularly in clinical roles, even as it pushes for productivity gains and staffing optimization. At the same time, a 1.3% reduction in the Medicare Home Health base rate constrains top-line growth, forcing Pennant to offset reimbursement pressure with efficiency improvements and disciplined cost control.</p>
<div class="lb-trans"><p>公司继续面临工资通胀，特别是在临床岗位上，即使在推动生产力提升和人员优化的同时。与此同时，医疗保险家庭健康基础费率降低 1.3% 限制了收入增长，迫使 Pennant 通过提高效率和严格控制成本来抵消报销压力。</p>
</div><h2>Elevated capex and one-time integration spending</h2>
<div class="lb-trans"><h2>高额资本支出和一次性整合支出</h2>
</div><p>Capital expenditures are elevated early in the year as Pennant invests in Senior Living integrations and infrastructure buildout in the Southeast. Management reiterated full-year capex expectations of roughly $15 million to $18 million, noting that spending is front-loaded and could present a near-term drag before benefits accrue.</p>
<div class="lb-trans"><p>年初资本支出较高，因为 Pennant 在东南部投资于老年生活整合和基础设施建设。管理层重申全年资本支出预期约为 1500 万至 1800 万美元，并指出支出是前期集中，可能在短期内造成拖累，直到收益显现。</p>
</div><h2>Regulatory scrutiny and hospice CAP exposure</h2>
<div class="lb-trans"><h2>监管审查和临终关怀 CAP 风险</h2>
</div><p>The company is closely monitoring hospice CAP constraints, with particular pressure in certain states, while acknowledging heightened regulatory focus on fraud, waste, and abuse. Management sees potential risk from broad enforcement actions but also views a cleaner competitive landscape as an opportunity as noncompliant operators exit.</p>
<div class="lb-trans"><p>公司正在密切关注临终关怀 CAP 限制，某些州面临特别压力，同时承认对欺诈、浪费和滥用的监管关注加大。管理层看到广泛执法行动带来的潜在风险，但也认为随着不合规运营商的退出，竞争环境的改善是一个机会。</p>
</div><h2>Conservative guidance amid integration uncertainty</h2>
<div class="lb-trans"><h2>在整合不确定性下的保守指引</h2>
</div><p>Pennant maintained its full-year guidance but indicated performance is tracking toward the upper end of the range, supported by double-digit revenue and EBITDA growth in the first quarter. Leadership signaled it will reassess after the second quarter, citing ongoing Southeast integration waves and a staged transition off the transition services agreement, as well as potential tailwinds from the proposed 2026 hospice rate increase.</p>
<div class="lb-trans"><p>Pennant 维持了全年指引，但表示业绩正朝着范围的上限发展，第一季度支持了双位数的收入和 EBITDA 增长。领导层表示将在第二季度后重新评估，提到东南部整合波的持续以及逐步退出过渡服务协议的过渡，以及 2026 年临终关怀费率提高的潜在利好。</p>
</div><p>Pennant’s earnings call painted a picture of a company in the midst of an aggressive but largely well-executed expansion, with strong revenue growth, rising EBITDA, and improving same-store metrics across key segments. Investors will now watch whether management can navigate EMR transitions, integration risk, and tighter liquidity without sacrificing the margin gains and volume momentum that underpinned this quarter’s performance.</p>
<div class="lb-trans"><p>Pennant 的财报电话会议描绘了一家正在进行激进但大体上执行良好的扩张公司的图景，强劲的收入增长、上升的 EBITDA 以及关键细分市场的同店指标改善。投资者现在将关注管理层是否能够在不牺牲本季度业绩支撑的利润率增长和交易量动能的情况下，顺利应对 EMR 过渡、整合风险和更紧的流动性。</p>
</div>

Pennant Group 在快速增长的同时平衡整合风险